ATE27456T1 - Kristallinische aenderungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate. - Google Patents

Kristallinische aenderungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.

Info

Publication number
ATE27456T1
ATE27456T1 AT83101707T AT83101707T ATE27456T1 AT E27456 T1 ATE27456 T1 AT E27456T1 AT 83101707 T AT83101707 T AT 83101707T AT 83101707 T AT83101707 T AT 83101707T AT E27456 T1 ATE27456 T1 AT E27456T1
Authority
AT
Austria
Prior art keywords
pharmaceutical preparations
processes
manufacture
preparations containing
crystalline modifications
Prior art date
Application number
AT83101707T
Other languages
English (en)
Inventor
Erwin Dr Marti
Oskar Heiber
Alexandre Dr Gumma
Gustave Dr Huber
Isamu Utsumi
Hiroshi Nakagawa
Tatsuhiko Miyata
Koichi Akimoto
Original Assignee
Zyma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zyma Sa filed Critical Zyma Sa
Application granted granted Critical
Publication of ATE27456T1 publication Critical patent/ATE27456T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT83101707T 1982-02-24 1983-02-22 Kristallinische aenderungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate. ATE27456T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8205453 1982-02-24
EP83101707A EP0087164B1 (de) 1982-02-24 1983-02-22 Kristallinische Änderungen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
ATE27456T1 true ATE27456T1 (de) 1987-06-15

Family

ID=10528576

Family Applications (2)

Application Number Title Priority Date Filing Date
AT83101707T ATE27456T1 (de) 1982-02-24 1983-02-22 Kristallinische aenderungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
AT0062083A AT383123B (de) 1982-02-24 1983-02-23 Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT0062083A AT383123B (de) 1982-02-24 1983-02-23 Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat

Country Status (30)

Country Link
US (1) US4515804A (de)
EP (1) EP0087164B1 (de)
JP (1) JPS58185578A (de)
KR (1) KR900006557B1 (de)
AT (2) ATE27456T1 (de)
AU (1) AU566685B2 (de)
BE (1) BE895991A (de)
CA (1) CA1212381A (de)
CH (1) CH654004A5 (de)
DD (1) DD208613A5 (de)
DE (2) DE3371785D1 (de)
DK (1) DK80983A (de)
ES (1) ES8504977A1 (de)
FI (1) FI76330C (de)
FR (1) FR2521995A1 (de)
GB (1) GB2115409B (de)
GR (1) GR77918B (de)
HU (1) HU194854B (de)
IL (1) IL67969A (de)
IN (1) IN157218B (de)
IT (1) IT1197582B (de)
LU (1) LU84657A1 (de)
NL (1) NL8300600A (de)
NO (1) NO830629L (de)
NZ (1) NZ203369A (de)
PH (1) PH20689A (de)
PL (1) PL141809B1 (de)
PT (1) PT76279B (de)
SE (1) SE8300974L (de)
ZA (1) ZA831216B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219384A (ja) * 1983-05-30 1984-12-10 Mitsui Norin Kk 天然抗酸化剤の製造方法
JPS6013780A (ja) * 1983-07-05 1985-01-24 Mitsui Norin Kk 茶カテキン類の製造方法
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
EP0263132A4 (de) * 1986-04-07 1988-11-16 Clemetson Ab Charles Mit catechin beschichtete ascorbinsäure und verfahren.
DE4316347C1 (de) * 1993-02-26 1994-08-18 Ina Dr Levi Verfahren zur Herstellung einer pharmazeutischen Zubereitung und Verwendung derselben zur Behandlung bestimmter Erkrankungen
WO1994022322A1 (en) * 1993-04-01 1994-10-13 Kalamazoo Holdings, Inc. Solid microcrystalline green tea catechin antioxidants for lipids
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US7108868B2 (en) * 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US8034387B2 (en) * 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
NZ535988A (en) 2002-04-30 2005-09-30 Unigen Pharmaceuticals Inc Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
CA2521429A1 (en) * 2003-04-04 2004-10-21 Unigen Pharmaceuticals, Inc. Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care
KR100545304B1 (ko) * 2004-09-01 2006-05-08 주식회사 유니젠 아선약을 포함하는 운카리아 속 식물, 또는 이의 황금및/또는 녹차의 배합물을 포함하는 사이클로옥시게나제및/또는 5-리폭시게나제 억제용 조성물
CN101747305B (zh) * 2008-11-28 2014-06-18 中国医学科学院药物研究所 硝克柳胺化合物晶v型、其制法和其药物组合物与用途
US11974982B2 (en) 2020-04-03 2024-05-07 The Board Of Trustees Of The University Of Illinois Stimulus-responsive antioxidant crystals and method for their preparation

Also Published As

Publication number Publication date
JPH032154B2 (de) 1991-01-14
AU566685B2 (en) 1987-10-29
NZ203369A (en) 1986-03-14
US4515804A (en) 1985-05-07
DK80983D0 (da) 1983-02-23
ATA62083A (de) 1986-10-15
FR2521995B1 (de) 1984-09-07
SE8300974L (sv) 1983-08-25
AT383123B (de) 1987-05-25
GB2115409A (en) 1983-09-07
HU194854B (en) 1988-03-28
FI76330C (fi) 1988-10-10
IT1197582B (it) 1988-12-06
EP0087164B1 (de) 1987-05-27
DE3306092A1 (de) 1983-09-01
FI76330B (fi) 1988-06-30
GR77918B (de) 1984-09-25
KR840003625A (ko) 1984-09-15
JPS58185578A (ja) 1983-10-29
ES519982A0 (es) 1985-04-16
EP0087164A1 (de) 1983-08-31
FI830571L (fi) 1983-08-25
CH654004A5 (de) 1986-01-31
CA1212381A (en) 1986-10-07
IL67969A0 (en) 1983-06-15
DK80983A (da) 1983-08-25
PL141809B1 (en) 1987-08-31
NO830629L (no) 1983-08-25
GB2115409B (en) 1985-08-07
PH20689A (en) 1987-03-24
PL240734A1 (en) 1984-11-08
BE895991A (fr) 1983-08-23
GB8302562D0 (en) 1983-03-02
SE8300974D0 (sv) 1983-02-22
PT76279A (en) 1983-03-01
KR900006557B1 (ko) 1990-09-13
IT8347760A0 (it) 1983-02-22
NL8300600A (nl) 1983-09-16
PT76279B (en) 1986-03-19
ZA831216B (en) 1985-03-27
IL67969A (en) 1986-11-30
DD208613A5 (de) 1984-04-04
FR2521995A1 (fr) 1983-08-26
IN157218B (de) 1986-02-15
ES8504977A1 (es) 1985-04-16
FI830571A0 (fi) 1983-02-21
LU84657A1 (de) 1983-09-08
AU1178583A (en) 1983-09-01
DE3371785D1 (en) 1987-07-02

Similar Documents

Publication Publication Date Title
ATE27456T1 (de) Kristallinische aenderungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
NO892762D0 (no) Fremgangsmaate for fremstilling av nye difosfonsyrederivater.
ATE151764T1 (de) Neue benzopyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltenden zubereitungen
DE3581566D1 (de) Oxindol-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte.
ATE45153T1 (de) Benzisoselenazolthione, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische produkte.
AU611113B2 (en) Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
SE8405588D0 (sv) New compounds
ATE74605T1 (de) Tetracyclische chinazolinderivate, herstellung und verwendung.
AU6814387A (en) Phenylacetonitriles which are substituted by basic groups, their preparation and drugs containing these substances
HUT49876A (en) Process for producing 6-oxopyridazine derivatives and pharmaceutical compositions comprising same
ATE46172T1 (de) Verbindungen, diese enthaltende pharmazeutische zusammensetzungen und verfahren zur herstellung.
NO872574D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler.
ATE100102T1 (de) Substituierte derivate von 20,21dinoreburnamenin, verfahren zur herstellung und so hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
DK159118C (da) 6alfa-methylprednisolon-derivater og farmaceutiske praeparater der indeholder dem

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee